This is made possible by a “linker” that attaches a toxin to a monoclonal antibody that then binds to a specific target expressed on a cancer cell.
Unlike conventional chemotherapy treatments that are toxic to healthy cells, antibody drug conjugates deliver chemotherapy agents directly to cancer cells. This is made possible by a “linker” that attaches a toxin to a monoclonal antibody that then binds to a specific target expressed on a cancer cell. By binding to the target, the ADC is able to release the cytotoxic drug directly into the cancer cell and avoid harming healthy cells.